BRC News

PPI 2.jpg

New guidance on public involvement in lab-based research has been published by the UCLH BRC, Alzheimer’s Society and Parkinson’s UK, in partnership with patients and researchers.
Vaccine AdobeStock_220120304.jpeg

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its ‘Phase 3’ trials which involved UCLH that show its candidate vaccine is effective at preventing COVID-19 and offers a high level of protection.
DSC05006 copy.jpg

A three year plan to improve the health and lives of people living with obesity has been launched by the Obesity Empowerment Network (OEN UK), which was co-founded by the BRC’s Obesity theme lead Professor Rachel Batterham.

UCLH is the first hospital in the world to treat a Covid-19 patient with nebulised (inhaled) surfactant – a substance which makes it easier to breathe – as part of a clinical trial. Lung surfactant is a substance that reduces the work of breathing and prevents the lungs from collapsing. In some